These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21497613)

  • 1. High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells.
    Hondebrink L; Meulenbelt J; Meijer M; van den Berg M; Westerink RH
    Neuropharmacology; 2011; 61(1-2):202-8. PubMed ID: 21497613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
    Hondebrink L; Meulenbelt J; Rietjens SJ; Meijer M; Westerink RH
    Neurotoxicology; 2012 Mar; 33(2):255-60. PubMed ID: 21996653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.
    Hondebrink L; Meulenbelt J; Timmerman JG; van den Berg M; Westerink RH
    J Neurochem; 2009 Oct; 111(2):624-33. PubMed ID: 19702656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual actions of lindane (γ-hexachlorocyclohexane) on calcium homeostasis and exocytosis in rat PC12 cells.
    Heusinkveld HJ; Thomas GO; Lamot I; van den Berg M; Kroese AB; Westerink RH
    Toxicol Appl Pharmacol; 2010 Oct; 248(1):12-9. PubMed ID: 20600211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct temperature-dependent dopamine-releasing effect of drugs of abuse in the olfactory bulb.
    Vizi ES; Palkovits M; Lendvai B; Baranyi M; Kovacs KJ; Zelles T
    Neurochem Int; 2004 Jul; 45(1):63-71. PubMed ID: 15082223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-related processes involved in the inhibition of depolarization-evoked calcium increase by hydroxylated PBDEs in PC12 cells.
    Dingemans MM; van den Berg M; Bergman A; Westerink RH
    Toxicol Sci; 2010 Apr; 114(2):302-9. PubMed ID: 20044592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole and imperatorin, the active constituents of Cnidium monnieri (L.) Cusson, facilitate glutamate release from rat hippocampal nerve terminals.
    Wang SJ; Lin TY; Lu CW; Huang WJ
    Neurochem Int; 2008 Dec; 53(6-8):416-23. PubMed ID: 18951936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
    Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of 20 non-dioxin-like PCBs on basal and depolarization-evoked intracellular calcium levels in PC12 cells.
    Langeveld WT; Meijer M; Westerink RH
    Toxicol Sci; 2012 Apr; 126(2):487-96. PubMed ID: 22218490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro.
    Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Monteiro Mdo C; Gonçalves MJ; Seabra V; Amado F; Carvalho F; Bastos ML
    Chem Res Toxicol; 2004 May; 17(5):623-32. PubMed ID: 15144219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells.
    Westerink RH; Klompmakers AA; Westenberg HG; Vijverberg HP
    Brain Res; 2002 Dec; 957(1):25-36. PubMed ID: 12443976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylarsine oxide is able to dissipate synaptic vesicle acidic pool.
    Tarasenko AS; Kostrzhevska OG; Storchak LG; Linetska MV; Borisova TA; Himmelreich NH
    Neurochem Int; 2005 Jun; 46(7):541-50. PubMed ID: 15843048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflurane Inhibits Dopaminergic Synaptic Vesicle Exocytosis Coupled to Ca
    Torturo CL; Zhou ZY; Ryan TA; Hemmings HC
    eNeuro; 2019; 6(1):. PubMed ID: 30680310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells.
    Ohara-Imaizumi M; Nakazawa K; Obama T; Fujimori K; Takanaka A; Inoue K
    J Pharmacol Exp Ther; 1991 Nov; 259(2):484-9. PubMed ID: 1658299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pardaxin induces exocytosis in bovine adrenal medullary chromaffin cells independent of calcium.
    Lazarovici P; Lelkes PI
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1317-26. PubMed ID: 1469638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.